“Polymeric Nanoparticle-Mediated Delivery of Oncolytic Measles Virus for Targeted Therapy in Cervical Cancer”. Pharmaceutical Communications, vol. 3, no. 1, June 2024, pp. 45-53, https://doi.org/10.55627/pharma.003.001.0887.